[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337206-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337206-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-commission-on-cancer-accreditation-with-receipt-of-guideline-concordant-care-and-survival-among-patients-with-colon-cancer","Association of commission on cancer accreditation with receipt of guideline-concordant care and survival among patients with colon cancer","","Guideline-concordant care (GCC) is linked to better outcomes in cancer, yet substantial variation in how often patients receive GCC remains. This retrospective observational study assessed whether Commission on Cancer (CoC) hospital accreditation relates to GCC receipt and survival in colon cancer patients. Patients diagnosed from 2018–2020 were drawn from the National Program of Cancer Registries and SEER database. Guideline concordance was defined by stage-appropriate lymphadenectomy or chemotherapy, using logistic and Cox regression to evaluate associations and 3-year cancer-specific mortality risk.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-commission-on-cancer-accreditation-with-receipt-of-guideline-concordant-care-and-survival-among-patients-with-colon-cancer/337206/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-commission-on-cancer-accreditation-with-receipt-of-guideline-concordant-care-and-survival-among-patients-with-colon-cancer/337206.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study define guideline-concordant care (GCC) for colon cancer?","Question",{"text":63,"@type":64},"GCC receipt was defined as receiving stage-appropriate lymphadenectomy or chemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What methods were used to study associations between CoC accreditation, GCC receipt, and survival?",{"text":68,"@type":64},"Multivariable logistic regression assessed associations with GCC receipt, and Cox proportional hazards regression evaluated 3-year cancer-specific mortality risk.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding CoC-accredited hospitals?",{"text":72,"@type":64},"Treatment at CoC-accredited hospitals was associated with increased receipt of guideline-concordant lymphadenectomy and chemotherapy, and it was linked to decreased risk-adjusted cancer mortality across stages I–IV.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337206,1790143711,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","DOI: 10. 1002/wjs.12391  \nORIGINAL RESEARCH  \nAssociation of commission on cancer accreditation with receipt of guideline‐concordant care and survival among patients with colon cancer  \nKelley Chan1,2  | Bryan E. Palis1 | Joseph H. Cotler1 |  \nLauren M. Janczewski1,3 | Ronald J. Weigel1,4 | David J. Bentrem3 | Clifford Y. Ko1,5  \n1American College of Surgeons Cancer Programs, Chicago, Illinois, USA  \n2Department of Surgery, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA  \n3Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA  \n4Department of Surgery, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA  \n5Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA  \nCorrespondence  \nKelley Chan, American College of Surgeons Cancer Programs, 633 N. St. Clair Street, 22nd Floor, Chicago, IL 60611, USA.  \nEmail: [kchan@facs.org](kchan@facs.org)  \nFunding information  \nAmerican College of Surgeons Clinical Scholars  \nAbstract  \nBackground: Guideline‐concordant care (GCC) is associated with improved survival for patients with cancer; however, variations in receipt of GCC remain a concern. The objective of this study was to evaluate the association of Commission on Cancer (CoC) hospital accreditation status with receipt of GCC and survival among patients with colon cancer. Methods: This retrospective observational study identified patients diagnosed with stage I–IV colon cancer from 2018 to 2020 from the National Program of Cancer Registries and Surveillance, Epidemiology, and End Results Program Database. Guideline concordance was defined as receipt of stage‐appropriate lymphadenectomy or chemotherapy. Multivariable logistic regression models investigated associations with receipt of GCC. Cox proportional hazards regression models assessed 3‐year cancer‐specific mortality risk.  \nResults: Of 222,583 patients with colon cancer, 146,629 (91 .2%) of eligible patients received guideline‐concordant lymphadenectomy and 70,586 (81 .9%) of the eligible patients received guideline‐concordant chemotherapy. Treatment at CoC‐accredited hospitals was the strongest modifiable predictor for receipt of guideline‐concordant lymphadenectomy (odds ratio [OR] 1.82; 95% confidence interval [CI] 1.75–1.88) and chemotherapy (OR 2. 14; 95% CI 2.06–2.23) . Among patients treated at CoC‐accredited hospitals, risk adjusted mortality was decreased for patients with stage I–II disease (hazard ratio [HR] 0.94; 95% CI 0.80–0.99), stage III disease (HR 0 .93; 95% CI 0.88–0.98), and stage IV disease (HR 0 .88; 95% CI 0.84–0.92) . Conclusions: For patients with colon cancer, treatment at CoC‐accredited hospitals was associated with increased receipt of GCC and decreased mortality risk. Benchmarking data may serve as a valuable accountability tool for quality assessment to improve cancer treatment and outcomes.  \nKEYWORDS  \ncolorectal, oncology, outcomes  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . World Journal of Surgery published by John Wiley & Sons Ltd on behalf of International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC) .  \n1 | INTRODUCTION  \nDespite the overall decline in mortality for patients with colon cancer in the United States, there remain significant disparities in progress observed nationally, which may reflect differences in access to and receipt of high‐ quality cancer treatment.1 National clinical guidelines were designed to promote standardization of care, minimize variability in treatment, and to improve quality of care.2 Receipt of guideline‐concordant care (GCC) has been associated with improved survival for patients with colon cancer.3 However, significant variations in the receipt of GC","cbCaiiBa2nwYqEu7","https://ap.wps.com/l/cbCaiiBa2nwYqEu7","pdf",607838,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Disparities and guideline-based quality measures\n## Commission on Cancer accreditation and benchmarking\n# Methods\n## Data source","[{\"question\":\"How did the study define guideline-concordant care (GCC) for colon cancer?\",\"answer\":\"GCC receipt was defined as receiving stage-appropriate lymphadenectomy or chemotherapy.\"},{\"question\":\"What methods were used to study associations between CoC accreditation, GCC receipt, and survival?\",\"answer\":\"Multivariable logistic regression assessed associations with GCC receipt, and Cox proportional hazards regression evaluated 3-year cancer-specific mortality risk.\"},{\"question\":\"What were the main findings regarding CoC-accredited hospitals?\",\"answer\":\"Treatment at CoC-accredited hospitals was associated with increased receipt of guideline-concordant lymphadenectomy and chemotherapy, and it was linked to decreased risk-adjusted cancer mortality across stages I–IV.\"}]","Association of commission on cancer accreditation with receipt of guideline-concordant care and survival among patients with colon cancer | PDF",1790018144,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9a4d0a216bb7da45c317e8905832e3f.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd82c3190769f12cce06e0f67e71ab92.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78c4fba2e7cd6f3e634879f991762b6a.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/961f625bf817f8dd2875ff673fa03953.webp",980,1287]